Dr Ajeet Singh

Dr. Ajeet Singh is a well-known private Psychiatrist who practices at The Geelong Clinic in the city of Geelong, Victoria. He has made significant contributions to the field of mental health throughout his career. Dr. Singh completed his medical degree, masters, and doctorate from The University of Melbourne. During his doctoral and post-doctoral work, he focused on blood-brain barrier Pharmacogenetics, which has helped him develop a deeper understanding of the topic. His expertise in this area led him to found a successful spinoff company, CNSDose, which received funding from The University of Melbourne and Texas Medical Centre. CNSDose later merged with a larger diagnostics firm, solidifying Dr. Singh's reputation as a respected professional in the industry. With over 100 academic publications and presentations, Dr. Singh has established himself as a distinguished academician and a prominent clinician. He is an author of both the current and past RANZCP mood disorders clinical practice guidelines, and he holds the position of adjunct Professor at Deakin Medical School. Moreover, Dr. Singh established the first regional clinical rTMS service in 2008, which remains operational to this day. This service has provided numerous patients with access to innovative mental health treatments. Currently, Dr. Singh is actively involved in developing artificial emotional intelligence systems for psychotherapy applications. This project demonstrates his commitment to scalable and affordable mental health innovations that can improve patient outcomes. Dr. Singh's dedication to the field of psychiatry extends beyond his clinical practice and academia, as he has also contributed to several task forces. For instance, he served on the Genetics in Psychiatry task force for the International Society of Psychiatric Genetics. Additionally, he is an author of the forthcoming 2023 Clinical Pharmacogenetics Implementation Consortium (NIH) guidelines on antidepressants. Dr. Ajeet Singh's extensive experience and expertise make him a valued practitioner and an asset to the mental health community. He is committed to continuously improving patient outcomes through his innovative approach to accessible mental health treatments.